Dissociation of μ-opioid receptor and CRF-R1 antagonist effects on escalated ethanol consumption and mPFC serotonin in C57BL/6J mice

Addiction Biology

Volumn 21, Issue 1, 2016, Pages 111-124

  Hwa, Lara S ^a   Shimamoto, Akiko ^a   Kayyali, Tala ^a   Norman, Kevin J ^a   Valentino, Rita J ^c   DeBold, Joseph F ^a   Miczek, Klaus A ^a,b  

^a TUFTS UNIVERSITY   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

CRF R1; dorsal raphe nucleus; intermittent alcohol; naltrexone

Indexed keywords

BUTYL[2,5 DIMETHYL 7 (2,4,6 TRIMETHYLPHENYL) 7H PYRROLO[2,3 D]PYRIMIDIN 4 YL]ETHYLAMINE; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; MU OPIATE RECEPTOR; NALTREXONE; SEROTONIN; (3,6-DIMETHYL-2-(2,4,6-TRIMETHYLPHENOXY)PYRIDIN-4-YL)(1-ETHYLPROPYL)AMINE; ALCOHOL; AMINOPYRIDINE DERIVATIVE; CENTRAL DEPRESSANT AGENT; CORTICOTROPIN RELEASING FACTOR RECEPTOR; NARCOTIC ANTAGONIST; PYRIMIDINE DERIVATIVE; PYRROLE DERIVATIVE; TRYPTOPHAN HYDROXYLASE;

ALCOHOL CONSUMPTION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN REGION; DORSAL RAPHE NUCLEUS; FOREBRAIN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LATERAL BRAIN VENTRICLE; MALE; MEDIAL PREFRONTAL CORTEX; MEDIAN RAPHE NUCLEUS; MOUSE; NERVE CELL; NEUROTRANSMISSION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SEROTONINERGIC NERVE CELL; SOMATIC CELL; ANIMAL; ANIMAL BEHAVIOR; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; DRINKING BEHAVIOR; DRUG EFFECTS; DRUG SELF ADMINISTRATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM; MICRODIALYSIS;

ALCOHOL DRINKING; AMINOPYRIDINES; ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DORSAL RAPHE NUCLEUS; ETHANOL; IMMUNOHISTOCHEMISTRY; INFUSIONS, INTRAVENTRICULAR; MALE; MICE; MICE, INBRED C57BL; MICRODIALYSIS; NALTREXONE; NARCOTIC ANTAGONISTS; PREFRONTAL CORTEX; PYRIMIDINES; PYRROLES; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RECEPTORS, OPIOID, MU; SELF ADMINISTRATION; SEROTONIN; TRYPTOPHAN HYDROXYLASE;

EID: 84957634156     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/adb.12189     Document Type: Article

References (51)

1. Altshuler HL, Phillips PE, Feinhandler DA, (1980) Alteration of ethanol self-administration by naltrexone. Life Sci 26: 679-688.
2. Amargõs-Bosch M, Bortolozzi A, Puig MV, Serrats J, Adell A, Celada P, Toth M, Mengod G, Artigas F, (2004) Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex. Cereb Cortex 14: 281-299.
3. Bosch O, Nair HP, Ahern TH, Neumann ID, Young LJ, (2008) The CRF system mediates increased passive stress-coping behavior following the loss of a bonded partner in a monogamous rodent. Neuropsychopharmacology 34: 1406-1415.
4. Chen YL, Obach RS, Braselton J, Corman ML, Forman J, Freeman J, Gallaschun RJ, Mansbach R, Schmidt AW, Sprouse JS, Tingley III FD, Winston E, Schulz DW, (2008) 2-Aryloxy-4-alkylaminopyridines: discovery of novel corticotropin-releasing factor 1 Antagonists. J Med Chem 51: 1385-1392.
5. Childers SR, (1991) Opioid receptor-coupled second messengers. Life Sci 48: 1991-2003.
6. Cippitelli A, Damadzic R, Singley E, Thorsell A, Ciccocioppo R, Eskay RL, Heilig M, (2012) Pharmacological blockade of corticotropin-releasing hormone receptor 1 (CRH1R) reduces voluntary consumption of high alcohol concentrations in non-dependent Wistar rats. Pharmacol Biochem Behav 100: 522-529.
7. Croop RS, Faulkner EB, Labriola DF, (1997) The safety profile of naltrexone in the treatment of alcoholism: results from a multicenter usage study. Arch Gen Psychiatry 54: 1130-1135.
8. Currie PJ, Fletcher PJ, Coscina DV, (1994) Administration of 8-OH-DPAT into the midbrain raphe nuclei: effects on medial hypothalamic NE-induced feeding. Am J Physiol 266: R1645-R1651.
9. Dimatelis JJ, Russell VA, Stein DJ, Daniels WM, (2012) The effects of lobeline and naltrexone on methamphetamine-induced place preference and striatal dopamine and serotonin levels in adolescent rats with a history of maternal separation. Metab Brain Dis 27: 351-361.
10. George O, Koob GF, (2010) Individual differences in prefrontal cortex function and the transition from drug use to drug dependence. Neurosci Biobehav Rev 35: 232-247.
11. George O, Sanders C, Freiling J, Grigoryan E, Vu S, Allen CD, Crawford E, Mandyam CD, Koob GF, (2012) Recruitment of medial prefrontal cortex neurons during alcohol withdrawal predicts cognitive impairment and excessive alcohol drinking. Proc Natl Acad Sci U S A 109: 18156-18161.
12. Gilpin NW, Richardson HN, Koob GF, (2008) Effects of CRF1-receptor and opioid-receptor antagonists on dependence-induced increases in alcohol drinking by alcohol-preferring (P) rats. Alcohol Clin Exp Res 32: 1535-1542.
13. Goldstein RZ, Volkow ND, (2002) Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 159: 1642-1652.
14. Heilig M, Koob GF, (2007) A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci 30: 399-406.
15. Hwa LS, Chu A, Levinson SA, Kayyali TM, DeBold JF, Miczek KA, (2011) Persistent escalation of alcohol drinking in C57BL/6J mice with intermittent access to 20% ethanol. Alcohol Clin Exp Res 35: 1938-1947.
16. Hwa LS, DeBold JF, Miczek KA, (2013) Alcohol in excess: CRF1 receptors in the rat and mouse VTA and DRN. Psychopharmacology (Berl) 225: 313-327.
17. Hwa LS, Kalinichev M, Haddouk H, Poli S, Miczek KA, (2014) Reduction of excessive alcohol drinking by a novel GABAB receptor positive allosteric modulator ADX71441 in mice. Psychopharmacology (Berl) 231: 333-343.
18. Imai H, Steindler DA, Kitai ST, (1986) The organization of divergent axonal projections from the midbrain raphe nuclei in the rat. J Comp Neurol 243: 363-380.
19. Kaminski BJ, Duke AN, Weerts EM, (2012) Effects of naltrexone on alcohol drinking patterns and extinction of alcohol seeking in baboons. Psychopharmacology (Berl) 223: 55-66.
20. Kirby LG, Freeman-Daniels E, Lemos JC, Nunan JD, Lamy C, Akanwa A, Beck SG, (2008) Corticotropin-releasing factor increases GABA synaptic activity and induces inward current in 5-hydoxytryptamine dorsal raphe neurons. J Neurosci 28: 12927-12937.
21. Kirby LG, Rice KC, Valentino RJ, (2000) Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus. Neuropsychopharmacology 22: 148-162.
22. Krystal JH, Cramer JA, Krol WF, Kirk GF, Rosenheck RA, (2001) Naltrexone in the treatment of alcohol dependence. N Engl J Med 345: 1734-1739.
23. Land BB, Bruchas MR, Lemos JC, Xu M, Melief EJ, Chavkin C, (2008) The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system. J Neurosci 28: 407-414.
24. Lê AD, Harding S, Juzytsch W, Fletcher PJ, Shaham Y, (2002) The role of corticotropin-releasing factor in the median raphe nucleus in relapse to alcohol. J Neurosci 22: 7844-7849.
25. Lechin F, van der Dijs B, Hernández-Adrián G, (2006) Dorsal raphe vs. median raphe serotonergic antagonism. Anatomical, physiological, behavioral, neuroendocrinological, neuropharmacological and clinical evidences: relevance for neuropharmacological therapy. Prog Neuropsychopharmacol Biol Psychiatry 30: 565-585.
26. Liu X, Weiss F, (2002) Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms. J Neurosci 22: 7856-7861.
27. Lowery EG, Thiele TE, (2010) Pre-clinical evidence that corticotropin-releasing factor (CRF) receptor antagonists are promising targets for pharmacological treatment of alcoholism. CNS Neurol Disord Drug Targets 9: 77-86.
28. Lowry CA, Rodda JE, Lightman SL, Ingram CD, (2000) Corticotropin-releasing factor increases in vitro firing rates of serotonergic neurons in the rat dorsal raphe nucleus: evidence for activation of a topographically organized mesolimbocortical serotonergic system. J Neurosci 20: 7728-7736.
29. Mantere T, Tupala E, Hall H, Särkioja T, Räsänen P, Bergström K, Callaway J, Tiihonen J, (2002) Serotonin transporter distribution and density in the cerebral cortex of alcoholic and nonalcoholic comparison subjects: a whole-hemisphere autoradiography study. Am J Psychiatry 159: 599-606.
30. Martignoni M, Groothuis GM, de Kanter R, (2006) Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opin Drug Metab Toxicol 2: 875-894.
31. Miczek KA, Winslow JT, (1987) Analgesia and decrement in operant performance in socially defeated mice: selective cross-tolerance to morphine and antagonism by naltrexone. Psychopharmacology (Berl) 92: 444-451.
32. Molander A, Vengeliene V, Heilig M, Wurst W, Deussing JM, Spanagel R, (2012) Brain-specific inactivation of the Crhr1 gene inhibits post-dependent and stress-induced alcohol intake, but does not affect relapse-like drinking. Neuropsychopharmacology 37: 1047-1056.
33. National Academy of Sciences (2011) Guide for the Care and Use of Laboratory Animals. 8th ed. The National Academies Press: Washington, D.C.
34. Price ML, Kirby LG, Valentino RJ, Lucki I, (2002) Evidence for corticotropin-releasing factor regulation of serotonin in the lateral septum during acute swim stress: adaptation produced by repeated swimming. Psychopharmacology (Berl) 162: 406-414.
35. Rolf RH, Matz DR, Brune GG, (1978) Serotonin metabolism in chronic alcoholism. Experientia 34: 74-75.
36. Sabino V, Cottone P, Koob GF, Steardo L, Lee MJ, Rice KC, Zorrilla EP, (2006) Dissociation between opioid and CRF1 antagonist sensitive drinking in Sardinian alcohol-preferring rats. Psychopharmacology (Berl) 189: 175-186.
37. Sabino V, Kwak J, Rice KC, Cottone P, (2013) Pharmacological characterization of the 20% alcohol intermittent access model in sardinian alcohol-preferring rats: a model of binge-like drinking. Alcohol Clin Exp Res 37: 635-643.
38. Schulz DW, Mansbach RS, Sprouse J, Braselton JP, Collins J, Corman M, Dunaiskis A, Faraci S, Schmidt AW, Seeger T, Seymour P, Tingley III FD, Winston EN, Chen YL, Heym J, (1996) CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors. Proc Natl Acad Sci U S A 93: 10477-10482.
39. Shimamoto A, DeBold JF, Holly EN, Miczek KA, (2011) Blunted accumbal dopamine response to cocaine following chronic social stress in female rats: exploring a link between depression and drug abuse. Psychopharmacology (Berl) 218: 271-279.
40. Simms JA, Nielsen CK, Li R, Bartlett SE, (2013) Intermittent access ethanol consumption dysregulates CRF function in the hypothalamus and is attenuated by the CRF-R1 antagonist, CP-376395. Addiction 19: 606-611.
41. Simms JA, Steensland P, Medina B, Abernathy KE, Chandler LJ, Wise R, Bartlett SE, (2008) Intermittent access to 20% ethanol induces high ethanol consumption in Long-Evans and Wistar rats. Alcohol Clin Exp Res 32: 1816-1823.
42. Staub DR, Lunden JW, Cathel AM, Delben EL, Kirby LG, (2012) Morphine history sensitizes postsynaptic GABA receptors on dorsal raphe neurons in a stress-induced releapse model in rats. Psychoneuroendocrinology 37: 859-870.
43. Takahashi A, Shimamoto A, Boyson CO, DeBold JF, Miczek KA, (2010) GABAB receptor modulation of serotonin neurons in the dorsal raphe nucleus and escalation of aggression in mice. J Neurosci 30: 11771-11780.
44. Tanahashi S, Yamamura S, Nakagawa M, Motomura E, Okada M, (2012) Effect of lamotrigine and carbamazepine on corticotropin-releasing factor-associated serotonergic transmission in rat dorsal raphe nucleus. Psychopharmacology (Berl) 220: 599-610.
45. Tao R, Auerbach SF, (1995) Involvement of the dorsal raphe but not median raphe nucleus in morphine-induced increases in serotonin release in the rat forebrain. Neuroscience 68: 553-561.
46. Tao R, Auerbach SF, (2005) μ-Opioids disinhibit and κ-opioids inhibit serotonin efflux in the dorsal raphe nucleus. Brain Res 104: 70-79.
47. A agonist, muscimol, increase voluntary ethanol intake in Wistar rats. Neuropharmacology 33: 349-358.
48. Van Pett K, Viau V, Bittencourt J, Chan RK, Li HY, Arias C, Prins GS, et al. (2000) Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 428: 191-212.
49. Walker BM, Valdez GR, McLaughlin JP, Bakalkin G, (2012) Targeting dynorphin/kappa opioid receptor systems to treat alcohol abuse and dependence. Alcohol 46: 359-370.
50. Waselus M, Nazzaro C, Valentino RJ, Van Bockstaele EJ, (2009) Stress-induced redistribution of corticotropin-releasing factor receptor subtypes in the dorsal raphe nucleus. Biol Psychiatry 66: 76-83.
51. Wise RA, (1973) Voluntary ethanol intake in rats following exposure to ethanol on various schedules. Psychopharmacologia 29: 203-210.